Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
US Stock MarketDetailed Quotes
BOW Bowhead Specialty
- 31.830
- -0.370-1.15%
Close Jan 8 16:00 ET
- 32.510
- +0.680+2.14%
Pre 04:16 ET
1.04BMarket Cap35.33P/E (TTM)
32.210High31.660Low76.40KVolume31.850Open32.200Pre Close2.44MTurnover0.38%Turnover Ratio38.96P/E (Static)32.66MShares37.81052wk High2.85P/B648.43MFloat Cap22.14052wk Low--Dividend TTM20.37MShs Float37.810Historical High--Div YieldTTM1.71%Amplitude22.140Historical Low31.899Avg Price1Lot Size
About Bowhead Specialty Company
Bowhead Specialty Holdings, Inc. engages in the provision of property and casualty insurance products through its subsidiaries. It focuses on underwriting casualty, professional liability, and healthcare risks. The company was founded by Stephen J. Sills in September 2020 and is headquartered in New York, NY.
Company Profile
SymbolBOW
Company NameBowhead Specialty
Listing DateMay 23, 2024
Issue Price17.00
Founded2020
CEOMr. Stephen J. Sills
MarketNYSE
Employees193
Fiscal Year Ends12-31
Address1411 Broadway,Suite 3800
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10018
Phone1-212-970-0269
Company Executives
- Name
- Position
- Salary
- Stephen J. Sills
- Director, Chief Executive Officer and President
- 1.39M
- Shirley Yap
- Chief Accounting Officer
- --
- David J. Newman
- Chief Underwriting Officer
- --
- Brad Mulcahey
- Chief Financial Officer and Treasurer
- 712.26K
- Matthew B. Botein
- Chairman of the Board
- --
- Dr. Ava Schnidman
- Director
- --
- Zhak Cohen
- Director
- --
- H. Matthew Crusey
- Director and General Counsel
- --
- Troy Van Beek
- Director
- --
- Fabian Fondriest
- Director
- --
- David Holman
- Independent Director
- 1.06M
- Angela Brock-Kyle
- Independent Director
- --
- Thomas Baker
- Independent Director
- --
- David T. Foy
- Independent Director
- --